Vatech, a global leader in dental imaging solutions, and Pearl, a frontrunner in dental AI technology, have announced a collaborative alliance aimed at transforming the landscape of dental diagnosis. By integrating Pearl's advanced AI-powered pathology detection capabilities into Vatech's diagnostic software, dental professionals worldwide will have access to unprecedented tools that enhance diagnostic precision and improve patient outcomes.

Vatech will seamlessly connect Pearl's Second Opinion® AI detection service to its renowned EzDent-i software. This connection will allow Vatech's software to interface with Pearl's AI technology to automatically detect a variety of dental conditions within a dentist's existing workflow. This seamless interaction will support faster and more accurate diagnoses. In addition, Vatech's upcoming integrated viewer software will also be designed to connect with this advanced AI capability, further improving diagnostic accuracy and operational efficiency.

"By embedding Pearl's Advanced AI solutions into our software, we are driving innovation in dental diagnosis," said Brian Hwang, CEO of Vatech. "This partnership strengthens our commitment to providing dental professionals with industry-leading technology that enhances diagnostic precision, streamlines clinical workflows, and ultimately improves patient care."

"We are thrilled to partner with Vatech to deliver our AI-powered detection technology to clinicians worldwide," said Ophir Tanz, Founder and CEO of Pearl. "This collaboration marks a significant step toward making AI-driven diagnostic support a standard part of dental practice, reducing the burden on clinicians while enhancing patient care."

In addition to Pearl and Vatech's joint efforts, Ewoosoft, an affiliated company of Vatech, will also play a key role in supporting the technical integration and rollout of these advanced AI capabilities. This collaboration further solidifies Vatech's position as a global leader in dental imaging innovation.

The newly enhanced diagnostic software will be set to debut in the first quarter of 2025, offering Vatech's customers next-generation pathology detection technology that augments clinical efficiency and diagnostic certainty.